Daniel L Cheney

age ~68

from Ringoes, NJ

Get Report

Also known as:

Daniel Lcheney
Dan Cheney
Dan L Mathew

Phone and address:: 39 Milestone Dr, East Amwell Township, NJ 08551
9082371116

Connected to:

Daniel Cheney Phones & Addresses

39 Milestone Dr, Ringoes, NJ 08551 • 9082371116
Collegeville, PA
Lynch, KY
Flemington, NJ
Audubon, PA
West Chester, PA
Ann Arbor, MI
39 Milestone Dr, Ringoes, NJ 08551

Work

Position:

Professional/Technical

Education

Degree:

Graduate or professional degree

Isbn (Books And Publications)

Shellfish and Seaweed Harvests of Puget Sound

view source

Author
Daniel P. Cheney

ISBN #
0295959908

Resumes

Technology Analyst At Humanized Communications

view source

Position:

Technology Analyst at Humanized Communications

Location:

Pierre, South Dakota

Industry:

Information Technology and Services

Work:

Humanized Communications - Greater Salt Lake City Area since Jan 2012
Technology Analyst
IncSpot Productions, LLC - Utah Oct 2001 - May 2013
Owner/Consultant
Delta Health Systems - Salt Lake City, Utah Oct 2009 - Oct 2011
IT Analyst
P5 Health Plan Solutions Jan 2004 - Oct 2009
IT Director
P5 Health Plan Solutions Jun 1999 - Jan 2004
IT Analyst/Project Director

Education:

University of Phoenix 1989 - 1991
BSBA, Business Administration University of Utah 1986 - 1989
Bachelor of Business Administration (BBA), Business Administration and Management, General Brigham Young University - Idaho 1982 - 1985
AA, Political Science SkyView High School 1979 - 1981

Skills:

SEO
InBound Marketing
Video Production
EDI
Microsoft Office
Budgeting
Social Media
iSeries
IBM iSeries
Wordpress
After Effects
Social Business Design
Web Development
Web Design
Business Analysis
Flash Professional
Network Administration
System Administration
Project Management
Security
Graphic Design
Analysis
Disaster Recovery
Business Intelligence
Management
Project Planning
Business Strategy
Systems Analysis
High Availability
Google Analytics
Networking
Web Project Management
IT Management
Web Analytics
E-commerce
Business Continuity
Team Leadership
Cloud Computing
Microsoft SQL Server
Software Development
DB2
Information Technology
Integration
Budgets
Testing
Databases
Technical Support
WordPress
Outsourcing
VPN

Interests:

Skiing, Web Design, Photography, Videography, Running, Spelunking, Family, Hiking, Camping, Reading,

Languages:

Portuguese

Research Fellow

view source

Location:

New York, NY

Industry:

Pharmaceuticals

Work:

Bristol-Myers Squibb
Research Fellow
Bristol-Myers Squibb
Senior Principal Scientist
Rhone-Poulence Rorer Dec 1988 - Oct 1997
Medicinal Chemist
University of Pretoria May 1988 - Sep 1988
Visiting Professor, Organic Chemistry
Warner Lambert Parke Davis Jun 1982 - Aug 1982
Summer Internship

Education:

Ohio State University 1984 - 1988
Doctorates, Doctor of Philosophy, Organic Chemistry

Daniel Cheney

view source

Name / Title

Company / Classification

Phones & Addresses

Daniel Cheney
Board of Directors

Lamb Foundation
Individual Family Services · Social Service & Welfare Organ

114 N Main St, North Wales, PA 19454
2156995600, 2156618825

Daniel L. Cheney
Secretary

SPRINGHOUSE FINANCIAL CORPORATION

111 Bethlehem Pike , Spring House, PA 19477

Us Patents

Acid Derivatives Useful As Serine Protease Inhibitors
view source
US Patent:

6642252, Nov 4, 2003
Filed:

Nov 7, 2001
Appl. No.:

10/052927
Inventors:

Gregory S. Bisacchi - Ringoes NJ
James C. Sutton - Princeton Junction NJ
William A. Slusarchyk - Skillman NJ
Uwe D. Treuner - Nittendorf, DE
Guohua Zhao - Princeton NJ
Daniel L. Cheney - Ringoes NJ
Yan Shi - Flourtown PA
Shung C. Wu - Princeton NJ
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C07D40102
US Classification:

514310, 514338, 514354, 546143, 5462734, 546323
Abstract:

Compounds having the formula (I), are useful as serine protease inhibitors, more particularly inhibitors of Factors VIIa, IXa, Xa, and/or XIa, wherein ring B is phenyl or pyridyl, W is preferably C( O)NR R , L is a linker group, X comprises nitrogen or carbon, Z is an optionally-substituted monocyclic or bicyclic ring system, and R , R , R , R , R and R are as defined in the specification.

Polynucleotide Encoding A Novel Human Serpin Secreted From Lymphoid Cells, Lsi-01
view source
US Patent:

7247717, Jul 24, 2007
Filed:

Nov 14, 2001
Appl. No.:

09/993180
Inventors:

Jian Chen - Princeton NJ, US
Thomas Nelson - Lawrenceville NJ, US
Daniel L. Cheney - Flemington NJ, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C12N 15/15
C12N 15/62
C12N 15/70
C12N 15/74
C12N 15/79
US Classification:

536 235, 435 692, 435 697, 4352523, 4353201, 536 234
Abstract:

The present invention provides novel polynucleotides encoding LSI-01 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LSI-01 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Polynucleotide Encoding A Novel Human Serpin Secreted From Lymphoid Cells, Lsi-01
view source
US Patent:

7256267, Aug 14, 2007
Filed:

Jan 11, 2006
Appl. No.:

11/329900
Inventors:

Jian Chen - Princeton NJ, US
Thomas Nelson - Lawrenceville NJ, US
Donna A Bassolino - Hamilton NJ, US
Daniel L. Cheney - Flemington NJ, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C07K 14/81
C07K 19/00
C12N 15/15
C12N 15/62
C12N 15/79
US Classification:

530350, 435 692, 435 697, 4352523, 4353201
Abstract:

The present invention provides novel polynucleotides encoding LSI-01 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LSI-01 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Sulfonyl Amide Inhibitors Of Calcium Channel Function
view source
US Patent:

7504431, Mar 17, 2009
Filed:

Apr 15, 2005
Appl. No.:

11/107218
Inventors:

Jon J. Hangeland - Morrisville PA, US
Daniel L. Cheney - Ringoes NJ, US
Todd J. Friends - Bordentown NJ, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

A61K 31/40
C07D 209/04
US Classification:

514428, 514365, 514415, 514534, 548203, 548469, 548530, 560 12
Abstract:

Compounds of formula I.

Macrocyclic Factor Viia Inhibitors Useful As Anticoagulants
view source
US Patent:

7592331, Sep 22, 2009
Filed:

Dec 21, 2006
Appl. No.:

11/614131
Inventors:

Eldon Scott Priestley - Yardley PA, US
Daniel L. Cheney - Ringoes NJ, US
Nicholas Ronald Wurtz - Pennington NJ, US
Peter W. Glunz - Yardley PA, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C07D 267/22
C07D 513/00
A61K 31/33
A61K 31/47
A61P 7/02
US Classification:

514183, 514307, 540456, 540460
Abstract:

The present invention relates generally to novel macrocycles of Formula (I):.

Bicyclic Lactam Factor Viia Inhibitors Useful As Anticoagulants
view source
US Patent:

8039506, Oct 18, 2011
Filed:

Dec 17, 2007
Appl. No.:

12/519365
Inventors:

Nicholas Ronald Wurtz - Pennington NJ, US
Eldon Scott Priestley - Yardley PA, US
Daniel L. Cheney - Ringoes NJ, US
Xiaojun Zhang - Furlong PA, US
Brandon Parkhurst - Twin Rivers NJ, US
Vladimir Ladziata - Ewing NJ, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

A61K 31/4035
US Classification:

514416, 548471, 548472
Abstract:

The present invention provides novel bicyclic lactams derivatives, and analogues thereof, of Formula (I):.

Macrocyclic Factor Viia Inhibitors Useful As Anticoagulants
view source
US Patent:

8420830, Apr 16, 2013
Filed:

Dec 19, 2007
Appl. No.:

12/519376
Inventors:

Nicholas Ronald Wurtz - Pennington NJ, US
Eldon Scott Priestley - Yardley PA, US
Daniel L. Cheney - Ringoes NJ, US
Peter W. Glunz - Yardley PA, US
Xiaojun Zhang - Furlong PA, US
Brandon Parkhurst - Twin Rivers NJ, US
Vladimir Ladziata - Ewing NJ, US
Luciano Mueller - Princeton NJ, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

A61K 31/405
US Classification:

548454, 548452, 548416, 548400, 514415, 514412, 514410, 514408, 514359
Abstract:

The present invention relates generally to novel macrocycles of Formula (I):.

Macrocyclic Factor Viia Inhibitors Useful As Anticoagulants
view source
US Patent:

20090281139, Nov 12, 2009
Filed:

Jul 23, 2009
Appl. No.:

12/507907
Inventors:

Eldon Scott Priestley - Yardley PA, US
Daniel L. Cheney - Ringoes NJ, US
Nicolas Ronald Wurtz - Pennington NJ, US
Peter W. Glunz - Yardley PA, US
International Classification:

A61K 31/4725
C07D 245/00
A61P 7/02
US Classification:

514310, 540456, 540460
Abstract:

The present invention relates generally to novel macrocycles of Formula (I):or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, L, M, W, Z, R, R, R, R, R, R, R, R, R, and Rare as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.